Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut de Cancérologie de Lorraine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Major patient
Patient with non-metastatic prostate or breast cancer
Newly diagnosed patients or those undergoing treatment
Patient able and willing to follow all study procedures in accordance with the protocol.
Patient having understood, signed and dated the consent form.
Patient affiliated to the social security system
Patient able to remain in a sitting position during the 2-hour session
You may not be if
Impossibility to undergo the medical follow-up of the trial for geographical, social or psychological reasons.
Presence of an acute psychiatric disorder: depression in acute phase, unstabilised bipolar disorder, psychotic disorders (delusions, hallucinations), etc.
Presence of recurrent uncontrolled panic attacks (notably linked to hypochondriac concerns)
Presence of latent or patent post-traumatic stress disorder
Lack of motivation to meditate
Insufficient attentional resources to meditate: major problems with attention, memory or reasoning
Patient with metastatic cancer.
Presence of cognitive and neurocognitive disorders and deficits
Presence of deafness
Membership in a meditation programme prior to inclusion
Clareo Health | Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)
